Coronary atherosclerosis in diabetes mellitus A population-based autopsy study by Goraya, Tauqir Y et al.
Coronary Atherosclerosis in Diabetes Mellitus
A Population-Based Autopsy Study
Tauqir Y. Goraya, MD, PHD,* Cynthia L. Leibson, PHD, Pasquale J. Palumbo, MD,‡
Susan A. Weston, MS,§ Jill M. Killian, BS,§ Eric A. Pfeifer, MD,† Steven J. Jacobsen, MD, PHD,
Robert L. Frye, MD,* Ve´ronique L. Roger, MD, MPH*
Rochester, Minnesota
OBJECTIVES The study was conducted to test the hypothesis that the prevalence of coronary atherosclerosis
is greater among diabetic than among nondiabetic individuals and is similar for diabetic
individuals without clinical coronary artery disease (CAD) and nondiabetics with clinical
CAD.
BACKGROUND Persons with diabetes but without clinical CAD encounter cardiovascular mortality similar to
nondiabetic individuals with clinical CAD. This excess mortality is not fully explained. We
examined the association between diabetes and coronary atherosclerosis in a geographically
defined autopsied population, while capitalizing on the autopsy rate and medical record
linkage system available via the Rochester Epidemiology Project, which allows rigorous
ascertainment of coronary atherosclerosis, clinical CAD, and diabetes.
METHODS Using two measures, namely a global coronary score and high-grade stenoses, the prevalence
of atherosclerosis was analyzed in a cohort of autopsied residents of Rochester, Minnesota,
age 30 years or older at death, while stratifying on diabetes, clinical CAD diagnosis, age, and
gender.
RESULTS In this cohort, diabetes was associated with a higher prevalence of atherosclerosis. Among
diabetic decedents without clinical CAD, almost three-fourths had high-grade coronary
atherosclerosis and more than half had multivessel disease. Without diabetes, women had less
atherosclerosis than men, but this female advantage was lost with diabetes. Among those
without clinical CAD, diabetes was associated with a global coronary disease burden and a
prevalence of high-grade atherosclerosis similar to that observed among nondiabetic subjects
with clinical CAD.
CONCLUSIONS These findings provide mechanistic insights into the excess risk of clinical CAD among
diabetic individuals, thereby supporting the need for aggressive prevention of atherosclerosis
in all diabetic individuals, irrespective of clinical CAD symptoms. (J Am Coll Cardiol 2002;
40:946–53) © 2002 by the American College of Cardiology Foundation
Individuals with diabetes have an increased risk of coronary
artery disease (CAD) morbidity and mortality (1–3). People
with type 2 diabetes experience higher rates of ischemic
events and death after a first myocardial infarction (MI)
(4–9); and in the absence of established CAD, they expe-
rience the burden of CAD at a rate equal to that of
nondiabetic individuals with established CAD (10,11). This
implies that prevention measures for asymptomatic diabetic
individuals should be similar to secondary prevention mea-
sures among nondiabetic individuals, a position recently
adopted by the American Diabetes Association and the
Joint National Committee VI (12,13). Whereas the cluster-
ing of other cardiac risk factors with diabetes suggests an
increased prevalence of atherosclerosis (4,7,14–16), the
mechanisms for increased clinical CAD burden in diabetes
are not fully defined. To this end, contrasting and specula-
tive reports point toward more severe anatomic CAD or
increased frequency of clinical events due to microvascular
disease or coagulation disturbances (17–20); yet the argu-
ment for aggressive preventive measures in diabetics is based
on the assumption of higher prevalence of atherosclerosis
among diabetic individuals even in the absence of clinical
CAD, despite the lack of anatomic data supporting this
approach. Angiographic case series, which include patients
referred to angiography with most often symptoms of CAD,
cannot, by design, define the burden of anatomic CAD in
asymptomatic subjects (21).
Prior autopsy studies in diabetics were subject to referral
bias owing to their hospital-based nature or to exceedingly
low autopsy rates in the source population (18), whereas
other studies were limited by small sample size (17–19,22–
24).
Higher autopsy rates in Rochester, Minnesota, combined
with detailed ascertainment of antemortem CAD and
diabetes, offer a unique opportunity to examine the ana-
tomic atherosclerotic burden according to the presence or
absence of diabetes among autopsied decedents in the
community. We tested the hypothesis that the prevalence of
coronary atherosclerosis was greater among diabetic than
among nondiabetic individuals and that the prevalence of
coronary atherosclerosis among diabetic individuals without
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antemortem CAD was similar to that among nondiabetics
with clinical antemortem CAD.
METHODS
Study setting and population. The environment in Olm-
sted County, Minnesota, provides a unique setting to assess
anatomic aspects of clinical diseases because its population is
served by a unified medical care system that has accumulated
comprehensive records over a long period of time and has
relatively high autopsy rates (25,26). Each care provider in
the county uses a unit medical record system whereby all
data are assembled in one place. These are easily retrievable
as the Rochester Epidemiology Project (AR-30582) devel-
oped extensive indices based on clinical and histologic
diagnoses and surgical procedures, resulting in the linkage
of all inpatient and outpatient medical records including
death certificates and autopsy reports for the entire county
population. For this study, all residents of Rochester who
had an autopsy between 1979 and 1994 and were age 30
years or older at time of death were included. Except for
coroner’s cases, the decision to perform an autopsy is made
on a case-by-case basis with the attending physician and the
family.
Conduct of the autopsy. All autopsies of persons dying in
hospitals or nursing homes and of coroner’s cases in Olm-
sted County are performed in the Medical Sciences Depart-
ment of Pathology at the Mayo Clinic, using uniform,
comprehensive, and standardized techniques (27). Both its
validity and its reproducibility were prospectively examined
and reported as all specimens are archived as part of the
Rochester Epidemiology Project Autopsy Registry (26).
The major extramural coronary arteries are examined by
serial transverse sectioning at 5-mm intervals. Arteries with
extensive calcification are dissected out intact and decalci-
fied before sectioning. The left main, left anterior descend-
ing, left circumflex, and right coronary arteries are graded in
ascending order of reduction in cross-sectional luminal area
by visual inspection by each prosector at the time of autopsy.
The semi-quantitative grading system reports on the degree
of reduction in luminal area including: grade 1, up to 25%
reduction; grade 2, 26% to 50% reduction; grade 3, 51% to
75% reduction; grade 4, 76% to 99% reduction; and grade 5,
complete occlusion. This standardized system was consis-
tently used during the study period (28,29).
Ascertainment of baseline characteristics and data col-
lection. The Rochester Epidemiology Project diagnostic
index was used to identify all Rochester decedents with
diabetes or diabetes-like condition (e.g., hyperglycemia,
elevated blood glucose, impaired glucose tolerance, diabetic
nephropathy) from the date of first contact with any care
provider until death. The median duration of medical
history available for review was 43 years (first-quartile–third
quartile  24 to 58 years). For autopsied decedents,
abstractors reviewed all medical records (including all labo-
ratory glucose values) to validate the diagnosis of diabetes,
using the criteria of the National Diabetes Data Group
(NDDG). These require two consecutive fasting glucose
levels of 140 mg/dl or more or 1- to 2-h levels of 200 mg/dl
or more obtained using a standard oral glucose tolerance test
(30). Published methods were used to adjust for temporal
changes in laboratory methods to measure glucose (31).
Several Rochester Epidemiology Project studies on diabetes
used these criteria (32–34). To select adult-onset diabetes,
only those decedents older than 30 years of age when they
first met NDDG criteria were included. In previous studies,
94% of diabetics in this age group were categorized as type
2 diabetes using an algorithm based on age, body mass
index, treatment, and evidence of ketosis (35). The abstrac-
tors collected demographic and autopsy data. Antemortem
diagnosis of CAD was ascertained with the Rochester
Epidemiology Project diagnostic index using all clinical
codes for angina, MI, and other forms of coronary disease.
Because autopsy data are used to assign the cause of death in
Olmsted County, only diagnoses made prior to death or
autopsy were included as clinical diagnosis. Deaths were
ascribed to CAD if the underlying cause of death on the
death certificate was coded as codes 410 through 414 of the
International Classification of Disease–9th revision.
Data analysis. Descriptive statistics used chi-square tests
for categorical variables and t tests or rank-sum tests for
continuous variables. Coronary atherosclerosis was analyzed
using two complementary methods focusing on four pre-
defined arterial segments including the left main, right,
circumflex, and left anterior descending coronary arteries.
First, for each patient we generated a summary coronary
score by summing the grades for each artery such that the
scores could take values ranging from 4 for grade 1 in each
segment to a maximum of 20 for grade 5 in each segment.
Three coronary score strata were constructed (4 to 9, 10 to
15, and 16 to 20). Second, we defined high-grade coronary
atherosclerosis as the presence of grade 3 or higher disease
in the left main, or grade 4 or higher disease in any of the
other three segments, using customary thresholds (36).
Multivessel disease was defined as the presence of high-
grade coronary atherosclerosis in either the left main or two
or more major coronary arteries. The prevalence of high-
grade atherosclerosis and the summary coronary scores were
compared between diabetic and nondiabetic individuals,
while stratifying on antemortem diagnosis of CAD, age,
and gender. Prevalence rates were compared using preva-
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
MI  myocardial infarction
NDDG  National Diabetes Data Group
OR  odds ratio
PR  prevalence ratio
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lence ratios with standard errors obtained using published
approaches (37). Each individual was classified into one of
four categories according to diabetes and antemortem CAD
statuses. Analysis of variance with Bonferroni correction for
multiple comparisons was used to compare the summary
coronary scores among groups. Logistic regression exam-
ined the association between high coronary score (defined as
10 or higher) and the categories representing diabetes/
antemortem CAD status while adjusting for age and gen-
der. To examine the generalizability to nonautopsied dece-
dents, referral to autopsy by diabetic status, age, gender, and
location of death of all decedents was examined. All aspects
of the study were approved by the Mayo Clinic Institutional
Review Board.
RESULTS
Baseline characteristics. The demographic and clinical
characteristics of 293 diabetic and 1,736 nondiabetic autop-
sied residents of Rochester are shown in Table 1. Age and
gender distributions were similar. Diabetic individuals had a
higher body mass index, were more likely to have clinical
CAD and to have left ventricular dilation, hypertrophy, and
evidence of MI.
Global atherosclerosis burden and high-grade athero-
sclerosis. The summary coronary score, an indicator of the
global atherosclerosis burden, had a mean value of 11.3  3.4
in diabetics, significantly higher than the mean of 9.8  3.6
among nondiabetics (p  0.0001). A greater percentage of
diabetics had higher scores in the upper two strata of the
scores as compared to nondiabetics (74% vs. 55%, p 
0.001).
The prevalence of high-grade atherosclerosis according to
diabetes, age, and gender is shown in Table 2. Among
diabetic decedents, 75% had high-grade coronary athero-
sclerosis versus only 55% among nondiabetic decedents
(prevalence ratio [PR], 1.3; 95%CI [confidence interval],
1.2 to 1.5, p  0.001). Among nondiabetics, the prevalence
of high-grade coronary atherosclerosis was higher in men
(62%) than in women (49%) (PR, 1.3; 95%CI, 1.2 to 1.4, p
 0.001). However, no gender difference was detected
Table 1. Demographic and Clinical Characteristics of Decedents
Undergoing Autopsy by Diabetes Status
Diabetes
(n  293)
No Diabetes
(n  1,763) p Value
Decedent characteristics
Male gender (%) 51 48 0.34
Mean age  SD 75  11 73  15 0.14
Out-of-hospital deaths (%) 54 56 0.52
Coroner’s cases (%) 44 47 0.41
Antemortem CAD (%) 49 33  0.001
Body mass index (kg/m2) 27  20 23  8  0.001
Autopsy results
Cardiac hypertrophy (%) 57 45  0.001
MI by autopsy (%) 49 35  0.001
LV dilation (%) 26 21 0.06
CAD  coronary artery disease; LV  left ventricle; MI  myocardial infarction.
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between diabetic men (79%) and diabetic women (70%)
(PR, 1.1; 95%CI, 1.0 to 1.3, p  0.07). The effect of
diabetes was most salient in younger women, with a PR for
diabetics versus nondiabetics of 2.5 (95%CI, 1.5 to 4.1).
The difference was not significant for young diabetic men
(PR, 1.1; 95%CI, 0.8 to 1.6, p  0.54).
Among older decedents, a modest increase in the preva-
lence of high-grade coronary atherosclerosis was observed
among both diabetic men and diabetic women relative to
their nondiabetic counterparts. The prevalence of multives-
sel high-grade atherosclerosis among diabetics and nondia-
betics by age and gender categories is presented in Table 2.
Multivessel high-grade CAD was present in 58% of the
diabetic decedents and 41% of nondiabetic decedents (p 
0.001). It was more prevalent in nondiabetic men than
among women, but no gender difference was detected in
diabetic persons. The effect of diabetes on the prevalence of
multivessel disease was greater in younger women (PR for
diabetes, 2.8; 95%CI, 1.6 to 5.1, p  0.001) than for
younger men (PR, 1.2; 95%CI, 0.8 to 1.9, p  0.34). Thus,
among younger women, the prevalence of multivessel dis-
ease increased from 18% in nondiabetic individuals to 50%
in diabetic individuals, thereby equating the prevalence of
45% in younger diabetic men (p  0.73).
Diabetes as an equivalent of clinical CAD. This analysis
examined whether diabetes was associated with an anatomic
coronary disease burden equivalent to that of individuals
with clinical CAD. Both indicators of atherosclerosis,
namely global coronary score and prevalence of high-grade
atherosclerosis, were examined in four strata defined by the
presence or absence of diabetes and clinical CAD, while
focusing on the contrast between individuals with diabetes
but without CAD and those with clinical CAD but no
diabetes.
The mean value of the coronary scores is shown in Figure
1. The scores were different between all groups except
between those with clinical CAD in whom the mean scores
were similar irrespective of diabetes status. With regards to
the contrast between diabetics without CAD and individ-
uals with clinical CAD, the global anatomic disease burden
was higher in persons with clinical CAD (11.6  3.1) as
compared to diabetics without clinical CAD (10.6  3.4,
p  0.001). After adjusting for age and gender, the relative
odds of having a higher coronary score increased stepwise
from diabetes without CAD (OR [odds ratio], 2.3; 95%CI,
1.7 to 3.5) to clinical CAD and no diabetes (OR, 3.1;
95%CI, 2.5 to 3.9) to clinical CAD and diabetes (OR, 4.6;
95%CI, 3.0 to 7.1). The OR for diabetes without CAD
compared to that of CAD with no diabetes was 0.78
(95%CI, 0.52 to 1.16), indicative of a nonsignificant differ-
ence in global anatomic disease burden between diabetes
alone and clinical CAD alone.
The prevalence of high-grade atherosclerosis, stratified by
age and gender, is presented in Figure 2.
Diabetic decedents (68%) were more likely than their
nondiabetic counterparts (46%) to have high-grade athero-
sclerosis (PR, 1.5; 95%CI, 1.3 to 1.7, p  0.001). Among
persons with clinical CAD during life, high-grade athero-
sclerosis was common irrespective of diabetes status (82%
and 75% in diabetics and nondiabetics, respectively, p 
0.10). Without antemortem CAD, 50% of the younger
diabetic men and 81% of the older diabetic men had
high-grade atherosclerosis at autopsy (Fig. 2A). Notably,
among older men, the prevalence of high-grade coronary
atherosclerosis was similar among diabetic individuals with-
out an antemortem CAD (81%) and nondiabetic individuals
with antemortem CAD (84%) (p  0.51). Thus, among
older men, diabetes is equivalent to clinical CAD, for the
prevalence of high-grade atherosclerosis.
In younger women without antemortem diagnosis of
CAD, the prevalence of high-grade coronary atherosclerosis
was 19% among nondiabetics, contrasted with 50% among
diabetic individuals (PR, 2.6; 95%CI, 1.3 to 5.1, p  0.001)
(Fig. 2B). Irrespective of age, diabetic women without
clinical CAD had a prevalence of high-grade coronary
atherosclerosis similar to that of nondiabetic women with
antemortem CAD. This implies that, in women of all ages,
diabetes is equivalent to clinical CAD for the prevalence of
high-grade atherosclerosis.
Multivessel disease was highly prevalent in the presence of
clinical CAD irrespective of diabetes status (67% in diabetic
and 63% in nondiabetic decedents, p  0.39). However,
among those without clinical CAD, 50% of diabetics had
multivessel CAD, versus only 31% among nondiabetics (PR
for diabetes, 1.6; 95%CI, 1.3 to 2.0, p  0.001). These
results, shown in Figures 2C and 2D, are similar to the
findings noted for the presence of any high-grade coronary
atherosclerosis. Analogous results were also noted when the
Figure 1. Distribution of global coronary scores by diabetes and clinical
coronary disease status. CHD  coronary heart disease; DM  diabetes
mellitus.
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presence of disease in the left anterior descending artery was
examined as a separate end point.
Referral to autopsy by diabetes status. Autopsy rates were
similar for diabetic (29%, n  293) and nondiabetic dece-
dents (28%, n  1736; p  0.36). Associations among age,
gender, location of death, antemortem diagnosis of CAD,
MI, or cerebrovascular disease and referral to autopsy did
not differ according to diabetes.
DISCUSSION
In this geographically defined autopsy cohort, the preva-
lence of coronary atherosclerosis was higher among diabetic
than among nondiabetic individuals. Among diabetic dece-
dents without clinical CAD, almost three-fourths had
high-grade coronary atherosclerosis and more than half had
multivessel coronary disease. In the absence of diabetes,
women had less atherosclerosis than men did, but this
female advantage was lost with diabetes. Diabetes among
persons without clinical CAD was associated with a global
coronary disease burden and a prevalence of high-grade
atherosclerosis similar to that observed among nondiabetic
persons with clinical CAD.
Diabetes and anatomic coronary disease. Whereas diabe-
tes is commonly thought of as associated with increased
atherosclerosis, anatomic data supporting this perception
are relatively scarce. Several (38) but not all angiographic
case series showed that coronary atherosclerosis was more
severe among patients with diabetes. However, these reports
include patients referred to angiography with most often
clinical symptoms of CAD, and they do not, by design,
define the burden of anatomic CAD in asymptomatic
persons (21). Prior autopsy studies indicated that coronary
atherosclerosis was more prevalent among diabetic than
among nondiabetic decedents (39), but their generalizability
was often limited by exceedingly low autopsy rates in the
source population, small sample size (17–19,22–24), or
referral bias (18). Autopsy data of several epidemiologic
cohorts, including the Framingham Heart Study and the
Honolulu Heart Program, detected univariate associations
between diabetes and coronary atherosclerosis, which were,
however (17,19,22–24), not confirmed after adjustment for
other risk factors. This led some to hypothesize the role of
nonatherosclerotic processes, such as microvascular disease
(20,40) or clotting disorders, to explain cardiovascular
events in diabetic persons. However, both small sample size
and the low use of autopsy in the source population hinder
the generalizability of these data.
The present study extends these observations by showing,
Figure 2. Prevalence of any high-grade or multivessel coronary atherosclerosis at autopsy by diabetes and clinical coronary disease status. Data are presented
by age and gender categories. (Top) Prevalence of any high-grade coronary atherosclerosis for (A) men and (B) women. (Bottom) Prevalence of multivessel
disease for (C) men and (D) women. The p values are for results of test for equality between groups, indicated by horizontal brackets. *p  0.01.
CAD  coronary artery disease.
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in a large autopsy cohort within a geographically defined
community with higher autopsy rates, that diabetic subjects
have increased coronary atherosclerosis relative to nondia-
betic subjects. Because there was no detectable difference in
referral to autopsy by diabetes status, these data provide
insight into the burden of coronary atherosclerosis among
all diabetics. This study does not address the etiologic link
between diabetes and atherosclerosis; rather, it addresses
from a public health perspective the population burden of
coronary disease among people with diabetes.
Diabetic women in the Framingham Heart Study exhib-
ited a greater vulnerability to cardiovascular complications
than did diabetic men (41). The Rancho Bernardo investi-
gators identified a similar gender effect with a higher
adjusted diabetes-associated relative risk for women than for
men (2), and they hypothesized that the higher risk of
diabetes in women was largely a function of their lower
cardiac mortality in the absence of diabetes (42). The
anatomic basis for this clinical observation was not clear,
however, as studies of subclinical atherosclerosis had not
identified an increased prevalence of atherosclerosis among
diabetic women (43,44). The findings presented herein
address this question by indicating that, among younger
women, the prevalence of coronary atherosclerosis in the
absence of diabetes was lower than among men. With
diabetes, however, the prevalence of atherosclerosis in
women increased to the level of men in all age groups,
thereby providing anatomic support for the clinical obser-
vation of the equalization of cardiac risk between men and
women with diabetes.
Diabetes as a clinical CAD equivalent and clinical
implications. Several studies including those from the
Rochester Epidemiology Project provide compelling evi-
dence that diabetes increases the risk of both fatal and
nonfatal cardiac events (8,9,11,45), and that, in the absence
of clinical CAD, people with diabetes experience cardiac
events at a rate equal to that of nondiabetics with established
CAD (10,11). This indicates that, in diabetic subjects,
aggressive prevention should precede the clinical onset of
CAD. Key to the implementation of this strategy is the
determination of the mechanisms for this increased risk and
whether diabetic subjects without clinical CAD have similar
extent of atherosclerosis compared with nondiabetic subjects
with clinical CAD. If this is true, this supports similar
risk-factor modification in both groups.
Few studies examined the prevalence of coronary athero-
sclerosis among diabetics according to the presence or
absence of clinical CAD. Using carotid ultrasound, the
Insulin Resistance Atherosclerosis Study showed similar
severity of atherosclerosis among diabetic subjects without
clinical CAD and nondiabetic subjects with clinical CAD
(46). As noted by the investigators, however, the relatively
small number of cases with clinical CAD limited their
ability to analyze results by gender, and the cohort design is
subject to the healthy participant effect (47). The study by
Waller et al. (18) reported that the prevalence of athero-
sclerosis at autopsy was similar among subjects with clinical
CAD and among those with diabetes. However, its design,
which is akin to case-control with its inherent biases, its
selection criteria (also a source of bias), and the referral bias
inherent in the restriction to subjects seen in a diabetes
clinic and who conceivably have more severe diabetes than
subjects followed in the primary care setting, all limit the
inference that can be drawn from these data. These meth-
odological concerns do not apply to the present population-
based study, which greatly enhances its robustness. It
provides a mechanistic explanation for the observed simi-
larity of cardiac events between diabetics without clinical
CAD and nondiabetics with clinical CAD by indicating
that the extent of anatomic atherosclerosis in these two
groups is similar. These indicate, in turn, that risk-factor
modification should be pursued as aggressively in asymp-
tomatic diabetic patients as in their nondiabetic counter-
parts with clinical CAD. Because the prevalence of other
cardiac risk factors, such as hypertension, hypercholesterol-
emia, and obesity, is high in people with diabetes (4,7,14–
16), preventive approaches should be addressed toward all
existing risk factors in any patient with diabetes (6,13,48–
50).
Study strengths and limitations. These results provide
important insights into the relation between diabetes and
coronary atherosclerosis, and some points should be kept in
mind to assist in the interpretation of the data.
Although the population of Rochester, Minnesota, is
becoming more diverse, its racial and ethnic composition
limits the generalization of these data to ethnic groups not
adequately represented in this population. Conversely,
quasi-complete insurance coverage in the county reduces
confounding by access to care (51). Whereas autopsy reports
were used to ascertain atherosclerosis, the classification was
used consistently over time. Moreover, a prospective review
of specimen, all archived as part of the Rochester Epidemi-
ology Project Autopsy Registry, indicated good to excellent
agreement between the report and the specimen review (26).
Death certificates are not reliable to ascertain diabetes
(33,52). In the present study, diabetes was determined via a
complete review of the medical records using rigorous
definitions (30), which excluded individuals who did not
meet NDDG criteria. Redefining diabetes to include all
decedents ever assigned a clinical diagnosis of diabetes
yielded similar results.
CONCLUSIONS
In this geographically defined autopsy cohort, the preva-
lence of coronary atherosclerosis was higher among diabetic
than among nondiabetic individuals. Among diabetic dece-
dents without clinical CAD, almost three-fourths had
high-grade coronary atherosclerosis and more than half had
multivessel disease. In the absence of diabetes, women had
less coronary atherosclerosis than did men, but this female
advantage was lost with diabetes. Among individuals with-
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out clinical CAD, diabetes was associated with a global
coronary disease burden and a prevalence of high-grade
atherosclerosis similar to that observed among nondiabetic
persons with clinical CAD. These data provide anatomic
support for approaching diabetes as “CAD risk equivalent”
in terms of risk-factor management.
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